MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0005919
Goldfish Pharma Private Limited
Goldfish Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹28.71 Cr
▼ 6% YoY
Net profit · FY 2024
₹4.05 Lakh
Net margin 0.1%
EBITDA · FY 2024
₹1.02 Cr
EBITDA margin 3.6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹4.48 Cr
Satisfied ₹2.64 Cr
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
About Goldfish Pharma Private Limited
Data last updated:
Goldfish Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2008PTC059097. Its GSTIN is 36AADCG1412A1ZG (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors Dinesh Reddy Bhimireddy and Bindhu Bhimireddy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 – 5 – 35/304/9/1/Nr Mythri Nagar Behind HUDA Truck Parking Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.71 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹4.05 Lakh (net margin 0.1%) and EBITDA of ₹1.02 Cr (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹4.48 Cr and satisfied charges of ₹2.64 Cr on record. Court records list 22 cases involving the company, including 1 filed by the company and 21 filed against it; 7 cases are pending.
Goldfish Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0005919). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999TG2008PTC059097
Registration Number 059097
Incorporation Date 12 May 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0005919
CIN history
Goldfish Pharma has one previous CIN (Corporate Identification Number): U74999AP2008PTC059097. The current CIN is U74999TG2008PTC059097, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TG2008PTC059097 | Current |
| U74999AP2008PTC059097 | Previous |
Recognitions & Rankings of Goldfish Pharma
Contact details
Goldfish Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address5 – 5 – 35/304/9/1/Nr Mythri Nagar Behind HUDA Truck Parking Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Goldfish Pharma Private Limited, buy the company report.
Comprehensive company report
Goldfish Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Goldfish Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Goldfish Pharma Private Limited, buy the company report.
Financials of Goldfish Pharma Private Limited
FY 2024 filings availableGoldfish Pharma Private Limited reported revenue of ₹28.71 Cr (down 6% YoY) for FY 2024.
Revenue · FY 2024
₹28.71 Cr ▼ 6%
Net profit · FY 2024
₹4.05 Lakh margin 0.1%
EBITDA · FY 2024
₹1.02 Cr margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 2%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 5%
5 years · compounded
▲ 9%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 6% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.02 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Goldfish Pharma Private Limited, buy the company report.
Board of directors of Goldfish Pharma Private Limited
Goldfish Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Reddy Bhimireddy Also directs: Bhimireddy Foods Private Limited | Director | 12 May 2008 | 18 Years 5 Months | Current |
| Bindhu Bhimireddy Also directs: Bhimireddy Foods Private Limited, Vainih Pharma Private Limited | Director | 27 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Goldfish Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sparsha Pharma International Private Limited | ₹29.04 Cr (FY 2025) | -4.0% | Hyderabad, Telangana, India | |||
| Curehealth Pharmaceuticals Private Limited | ₹29.03 Cr (FY 2024) | 47.0% | Chandigarh, India | |||
| Torino Laboratories Private Limited | ₹28.73 Cr (FY 2025) | 156.0% | Mumbai, Maharashtra, India | |||
| Goldfish Pharma Private Limitedthis company | ₹28.71 Cr (FY 2024) | ₹4.05 Lakh | 0.1% | -6.0% | Hyderabad, Telangana, India | |
| Ceego Labs Private Limited | ₹28.61 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Texas Lifesciences Private Limited | ₹28.6 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Ives Drugs ( India) Pvt.Ltd. | ₹28.6 Cr (FY 2025) | -8.0% | Indore, Madhya Pradesh, India | |||
| Zazen Pharma Private Limited | ₹28.58 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Goldfish Pharma Private Limited, buy the company report.
Auditor
Goldfish Pharma Private Limited is audited by G A REDDY & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G A REDDY & CO | FY 2021 | 021663S |
Shareholding
The shareholding of Goldfish Pharma Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Goldfish Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.48 Cr
Satisfied charges
₹2.64 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jun 2017 | 100111282 | Others | ₹3.28 Cr | Open | |
| 25 Sep 2013 | 10460776 | Bank of India | ₹1.2 Cr | Open | |
| 29 May 2017 | 100107380 | Others | ₹75.56 Lakh | Satisfied | |
| 06 Jan 2015 | 10584818 | Dewan Housing Finance Corporation Limited | ₹1.88 Cr | Satisfied |
To see the full charge records of Goldfish Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Goldfish Pharma Private Limited has 22 court cases on record: 1 filed by Goldfish Pharma, 21 filed against it. 7 cases are pending and 15 are disposed.
Total cases
22
Filed by the company
1
Filed against the company
21
Pending
7
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 20 | 7 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Akhil Healthcare Pvt Ltd. - Authorised Signatory Mr. Pratapbhai Samantbhai Padhiyar | Pending |
| District court, Solapur, Maharashtra | Civil suit | Filed against the company by Smruthi Organics Ltd | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Pending |
| District court, South, Delhi | Commercial suit | Filed against the company by Emu Lines Pvt.Ltd. | Disposed |
| District court, South, Delhi | Civil suit | Filed against the company by Emu Lines Pvt. Ltd. | Disposed |
To see the full case history of Goldfish Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Goldfish Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Goldfish Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCG1412A1ZG | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Goldfish Pharma Private Limited, buy the company report.
Recent activity
Goldfish Pharma Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Bhimireddy Jayalakshmi ceased to be Director on 05 Dec 2025.
Ceased
Bhimireddy Jayalakshmi ceased to be Director.
AGM
Goldfish Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Goldfish Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 29 May 2017 via Charge ID 100107380 with Others was fully satisfied on 29 Jul 2022.
Charges
A charge with Bank Of India of Rs. 1.20 Cr registered on 25 Sep 2013 with Charge ID 10460776 was modified on 05 Aug 2021.
Appointed
Bindhu Bhimireddy was appointed as Director.
Ceased
Bindhu Bhimireddy ceased to be Director.
Ceased
Bhimireddy Jyothi ceased to be Director.
Ceased
Bhimireddy Reddy Ramesh ceased to be Director.
Charges
A charge registered on 06 Jan 2015 via Charge ID 10584818 with Dewan Housing Finance Corporation Limited was fully satisfied on 09 Aug 2017.
Charges
A charge with Others amounted to Rs. 3.28 Cr with Charge ID 100111282 was registered on 05 Jun 2017.
Charges
A charge with Others amounted to Rs. 0.76 Cr with Charge ID 100107380 was registered on 29 May 2017.
4 earlier events are in the company report.
Frequently asked questions
Goldfish Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 2008 (18+ years old) and is registered under CIN U74999TG2008PTC059097.
Goldfish Pharma has 2 current directors:
- Dinesh Reddy Bhimireddy - Director
- Bindhu Bhimireddy - Director
The latest financial statements of Goldfish Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Goldfish Pharma is 36AADCG1412A1ZG, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Goldfish Pharma is U74999TG2008PTC059097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Goldfish Pharma has 22 court cases on record: 1 filed by the company and 21 filed against it. 7 are pending. Most are in the district courts.
Goldfish Pharma was incorporated on 12 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Goldfish Pharma by revenue are Sparsha Pharma International Private Limited, Curehealth Pharmaceuticals Private Limited, Torino Laboratories Private Limited, Ceego Labs Private Limited, Texas Lifesciences Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhimireddy Jayalakshmi ceased to be Director on 05 Dec 2025. Bindhu Bhimireddy was appointed as Director on 27 Mar 2019. Bindhu Bhimireddy ceased to be Director on 15 Jan 2019. Goldfish Pharma has 6 board changes on record in total.
Yes, Goldfish Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0005919).
The registered office of Goldfish Pharma is at 5 – 5 – 3530491Nr Mythri Nagar Behind HUDA Truck Parking Kukatpally, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages